Vaccinogen, Inc. VGEN Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Vaccinogen, Inc. VGEN Company Overview 

Stock Message Board http://investorshangout.com/search?q=VGEN&...mp;yt1=Go!

Vaccinogen, Inc. VGEN Current Price and Quotes
Last Price 6.00
Previous Close 6.00 Open N/A
Daily Range N/A - N/A 52wk Range 7.00 - 5.50
Volume 0 Dividend N/A
Average Vol (3m) 658 Yield N/A
Vaccinogen, Inc. VGEN

Company Verified Profile
Company Information

5300 Westeview Drive
Suite 406
Frederick, MD 21703

Phone: 301-668-8400

Vaccinogen, Inc. VGEN
Vaccinogen is a biotechnology company focused on the development and commercialization cancer vaccines and immunotherapeutic products for cancers and infectious diseases.

Vaccinogen, Inc. VGEN
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Audited Financials Audited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001453001
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: MD, USA
Year of Inc. 2007
Employees Not Available
Company Officers/Contacts

Michael Hanna, Jr. CEO
Andrew L Tussing President
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Indeglia & Carney
1900 Main St.
Irvine, CA, 92614
United States

Investor Relations Firm
Not Available

Vaccinogen, Inc. VGEN
VGEN Security Details

Share Structure

Market Value1 $187,396,536 a/o Sep 13, 2013
Shares Outstanding 31,232,756 a/o Jun 30, 2013
Float Not Available
Authorized Shares 200,000,000 a/o Jun 30, 2013
Par Value  0.0001
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest 0 (-100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Globex Transfer, LLC

Vaccinogen, Inc. VGEN Recent News

Vaccinogen, Inc. VGEN Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses

Research and Development 8,139 8,565
Sales, General and Admin. 2,961 2,783
Non-Recurring Items - -
Other - -
Operating Income (11,100) (11,348)
Income From Continuing Operations

Add'l Income/Expense Items (1,282) -
Earnings Before Interest and Tax (12,382) (11,348)
Interest Expense 312 176
Earnings Before Tax (12,694) (11,524)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (12,694) (11,524)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (12,694) (11,524)
Preferred Stock and Other Adjustments (16,518) (27,668)
Net Income Applicable to Common Shareholders (29,212) (39,192)

VGEN Vaccinogen, Inc. Research DD Guide

VGEN Vaccinogen, Inc. Stock Message Board http://investorshangout.com/search?q=VGEN&...mp;yt0=Go!
VGEN Vaccinogen, Inc. Stock Quote http://www.otcmarkets.com/stock/VGEN/quote
VGEN Vaccinogen, Inc. Stock Chart http://www.otcmarkets.com/stock/VGEN/chart
VGEN Vaccinogen, Inc. Company Info http://www.otcmarkets.com/stock/VGEN/company-info
VGEN Vaccinogen, Inc. Recent News http://www.otcmarkets.com/stock/VGEN/news
VGEN Vaccinogen, Inc. Financials http://www.otcmarkets.com/stock/VGEN/financials
VGEN Vaccinogen, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/VGEN/filings
VGEN Vaccinogen, Inc. Short Sales http://www.otcmarkets.com/stock/VGEN/short-sales
VGEN Vaccinogen, Inc. Insider Disclosure http://www.otcmarkets.com/stock/VGEN/insider-transactions
VGEN Vaccinogen, Inc. Research Reports http://www.otcmarkets.com/stock/VGEN/research
VGEN Vaccinogen, Inc. Summary http://finance.yahoo.com/q?s=VGEN
VGEN Vaccinogen, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=VGEN+Historical+Prices
VGEN Vaccinogen, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=VGEN
VGEN Vaccinogen, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=VGEN+Basic+Chart
VGEN Vaccinogen, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=VGEN+Basic+Tech.+Analysis
VGEN Vaccinogen, Inc. Headlines http://finance.yahoo.com/q/h?s=VGEN+Headlines
VGEN Vaccinogen, Inc. Press Releases http://finance.yahoo.com/q/p?s=VGEN+Press+Releases
VGEN Vaccinogen, Inc. Company Profile http://finance.yahoo.com/q/pr?s=VGEN+Profile
VGEN Vaccinogen, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=VGEN+Key+Statistics
VGEN Vaccinogen, Inc. Industry http://finance.yahoo.com/q/in?s=VGEN+Industry
VGEN Vaccinogen, Inc. Major Holders http://finance.yahoo.com/q/mh?s=VGEN+Major+Holders
VGEN Vaccinogen, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=VGEN+Insider+Transactions
VGEN Vaccinogen, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=VGEN+Insider+Roster
VGEN Vaccinogen, Inc. Income Statement http://finance.yahoo.com/q/is?s=VGEN
VGEN Vaccinogen, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=VGEN
VGEN Vaccinogen, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=VGEN+Cash+Flow&annual
VGEN Vaccinogen, Inc. Nasdaq http://www.nasdaq.com/symbol/VGEN
VGEN Vaccinogen, Inc. Market Watch http://www.marketwatch.com/investing/stock/VGEN
VGEN Vaccinogen, Inc. Bloomberg http://www.bloomberg.com/quote/VGEN:US
VGEN Vaccinogen, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=VGEN
VGEN Vaccinogen, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=VGEN
VGEN Vaccinogen, Inc. Barchart http://www.barchart.com/quotes/stocks/VGEN
VGEN Vaccinogen, Inc. OTC Short Report http://otcshortreport.com/index.php?index=VGEN
VGEN Vaccinogen, Inc. Investopedia http://www.investopedia.com/markets/stocks/VGEN/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 428

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 221

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 291

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

WellCare of Kentucky Partners with Owen County for Transit Grant

Updated Category News Views 139

WellCare of Kentucky Collaborates with Owen County for a Transportation Grant Improving transportation access for rural residents is essential to reducing barriers for medical visits and other important commitments. WellCare of Kentucky has announced a significant initiative that reflects this commitment by awarding Owen County Public Transit (OCPT) a grant worth $20,000....

Continue Reading
Domo Delivers Strong Growth in Q3 Fiscal 2025 Results

Updated Category News Views 117

Domo Reports Impressive Third Quarter Fiscal 2025 Results Domo, Inc. (Nasdaq: DOMO) has recently released its financial results for the fiscal third quarter, revealing significant growth and promising outlooks for the future. The company recorded a total revenue of $79.8 million, marking a strong performance driven by a $71.1 million subscription revenue component. The...

Continue Reading
Goodfellow Inc. Announces Q3 Earnings and Dividend Update

Updated Category News Views 73

Goodfellow Inc. Declares Q3 Financial Results and Dividend Goodfellow Inc. (TSX: GDL), a prominent name in the wood manufacturing and distribution sector, has recently shared its financial performance for the third quarter. Reporting net earnings of $5.8 million, or $0.68 per share, the figures show a slight decline from last year when net earnings reached $6.2 million at...

Continue Reading
Engagement and Health Awareness at ¡Vive Tu Vida! Event

Updated Category News Views 176

Engagement and Health Awareness at ¡Vive Tu Vida! Event The Mexican American Opportunity Foundation (MAOF) is set to host a spectacular health and wellness fair known as ¡Vive tu vida! Get Up! Get Moving!, where families will gather to celebrate health and promote physical activity. This much-anticipated event underscores the importance of community involvement in...

Continue Reading
Orca Scan Unveils Innovative Tool for Effortless Barcode Design

Updated Category News Views 105

Revolutionizing Barcode Generation with Orca Scan Creating barcodes has now become more accessible thanks to Orca Scan, a dynamic player in the software industry. The company recently unveiled an innovative barcode label designer aimed at streamlining the barcode creation process for users worldwide. This new tool provides enhanced functionality for businesses seeking...

Continue Reading